Harris Erik - Insider Non-Derivative Transactions at Ultragenyx Pharmaceutical Inc. (RARE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 1, 2024, Harris Erik's relationship to Ultragenyx Pharmaceutical Inc. (RARE) is Officer (EVP & Chief Commercial Officer), and currently has 71,638 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RARE insiders.
Data Source: SEC.
Harris Erik - Insider Non-Derivative Transactions of RARE Common Stock
Harris Erik - Insider Non-Derivative Transactions at RARE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 2, 2024 | Sell -- (Common Stock) | 4768 | 53.76 | 67163 |
| Mar 2, 2024 | Acquisition -- (Common Stock) | 19400 | 0 | 70681 |
| Mar 2, 2024 | Acquisition -- (Common Stock) | 957 | 0 | 71638 |
| Sep 6, 2023 | Sell -- (Common Stock) | 6000 | 37.96 | 51281 |
| Jun 20, 2023 | Sell -- (Common Stock) | 305 | 48.2 | 57281 |
| Mar 2, 2023 | Acquisition -- (Common Stock) | 2663 | 0 | 38823 |
| Mar 2, 2023 | Sell -- (Common Stock) | 3664 | 45.25 | 57344 |
| Mar 2, 2023 | Acquisition -- (Common Stock) | 22000 | 0 | 60823 |